426 related articles for article (PubMed ID: 19271275)
1. Rosuvastatin in patients with elevated C-reactive protein.
Jenny-Avital ER
N Engl J Med; 2009 Mar; 360(10):1039; author reply 1041-2. PubMed ID: 19271275
[No Abstract] [Full Text] [Related]
2. Rosuvastatin in patients with elevated C-reactive protein.
Chan PS; Nallamothu BK; Hayward RA
N Engl J Med; 2009 Mar; 360(10):1039; author reply 1041-2. PubMed ID: 19271273
[No Abstract] [Full Text] [Related]
3. Rosuvastatin in patients with elevated C-reactive protein.
Koller MT; Bucher HC; Steyerberg EW
N Engl J Med; 2009 Mar; 360(10):1041; author reply 1041-2. PubMed ID: 19271276
[No Abstract] [Full Text] [Related]
4. JUPITER study highlights value of anti-inflammatory action of rosuvastatin.
Cardiovasc J Afr; 2009; 20(3):211. PubMed ID: 19575096
[No Abstract] [Full Text] [Related]
5. Rosuvastatin in patients with elevated C-reactive protein.
Pierard LA
N Engl J Med; 2009 Mar; 360(10):1040; author reply 1041-2. PubMed ID: 19271277
[No Abstract] [Full Text] [Related]
6. Rosuvastatin in patients with elevated C-reactive protein.
Gibbons RJ
N Engl J Med; 2009 Mar; 360(10):1038; author reply 1041-2. PubMed ID: 19264695
[No Abstract] [Full Text] [Related]
7. [Statin cuts cardiovascular risk in half].
Einecke D
MMW Fortschr Med; 2008 Dec; 150(49-50):12-3. PubMed ID: 19133364
[No Abstract] [Full Text] [Related]
8. [JUPITER can yield paradigmatic shift in the prevention of cardiovascular disease. Focus on inflammation as a risk factor].
Olsson AG
Lakartidningen; 2009 May 20-Jun 2; 106(21-22):1471-5. PubMed ID: 19579435
[No Abstract] [Full Text] [Related]
9. Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: rationale and design of the JUPITER trial.
Ridker PM;
Circulation; 2003 Nov; 108(19):2292-7. PubMed ID: 14609996
[No Abstract] [Full Text] [Related]
10. [Less vascular risk with rosuvastatin in elevated CRP].
Bredie B
Ned Tijdschr Geneeskd; 2009 Feb; 153(6):245. PubMed ID: 19271446
[No Abstract] [Full Text] [Related]
11. Predicting benefit from statins by C-reactive protein, LDL-cholesterol or absolute cardiovascular risk.
Stewart RA
Future Cardiol; 2009 May; 5(3):231-6. PubMed ID: 19656039
[TBL] [Abstract][Full Text] [Related]
12. The JUPITER Trial: responding to the critics.
Ridker PM; Glynn RJ
Am J Cardiol; 2010 Nov; 106(9):1351-6. PubMed ID: 21029837
[No Abstract] [Full Text] [Related]
13. Cardiovascular health. Statin therapy reduces disease in healthy volunteers--but how, exactly?
Couzin J
Science; 2008 Nov; 322(5904):1039. PubMed ID: 19008423
[No Abstract] [Full Text] [Related]
14. Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial.
Sniderman AD
Lancet; 2009 Jul; 374(9683):25; author reply 26-7. PubMed ID: 19577690
[No Abstract] [Full Text] [Related]
15. [JUPITER study (2). For now no reason to give statins to more people].
Koopmans RP
Ned Tijdschr Geneeskd; 2009 Feb; 153(6):218-9. PubMed ID: 19271439
[No Abstract] [Full Text] [Related]
16. Low-risk older patients (50 years and older) with raised high-sensitivity CRP (hs-CRP) benefit from rosuvastatin therapy: the JUPITER study.
Cardiovasc J Afr; 2008; 19(6):332-4, discussion 335. PubMed ID: 19104734
[No Abstract] [Full Text] [Related]
17. [JUPITER no support of changed guidelines for cardiovascular prevention. Moderate absolute risk reduction and uncertain long term effects].
Håkansson J
Lakartidningen; 2009 May 20-Jun 2; 106(21-22):1460-1. PubMed ID: 19579433
[No Abstract] [Full Text] [Related]
18. Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial.
de Tena JG
Lancet; 2009 Jul; 374(9683):24; author reply 26-7. PubMed ID: 19577686
[No Abstract] [Full Text] [Related]
19. Primary prevention of vascular events in patients with high levels of C-reactive protein: the JUPITER study.
Fonseca FA; Izar MC
Expert Rev Cardiovasc Ther; 2009 Sep; 7(9):1041-56. PubMed ID: 19764857
[TBL] [Abstract][Full Text] [Related]
20. The editor's roundtable: the JUPITER trial--initial results and clinical implications.
Ridker PM; Friedewald VE; Davidson MH; Willerson JT; Roberts WC
Am J Cardiol; 2009 May; 103(10):1417-25. PubMed ID: 19427439
[No Abstract] [Full Text] [Related]
[Next] [New Search]
